These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 31466)

  • 21. Investigation of neurotransmission in vas deferens from alpha(2A/D)-adrenoceptor knockout mice.
    Cleary L; Vandeputte C; Docherty JR
    Br J Pharmacol; 2002 Jul; 136(6):857-64. PubMed ID: 12110610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Profiles of the response to noradrenaline in the whole and bisected rat vas deferens.
    Boselli C; Bianchi L; Grana E
    J Auton Pharmacol; 1997 Apr; 17(2):97-107. PubMed ID: 9234080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of cocaine on the contractile response to noradrenaline in the epididymal and prostatic regions of the vas deferens].
    Berdysheva LV; Kichikulova TP; Manukhin BN
    Ross Fiziol Zh Im I M Sechenova; 1999 Aug; 85(8):1090-4. PubMed ID: 10643604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of prazosin and phentolamine on responses to field stimulation and to noradrenaline in vas deferens and anococcygeus muscle of the rat.
    Doggrell SA; Paton DM
    Arch Int Pharmacodyn Ther; 1978 Jun; 233(2):209-20. PubMed ID: 686912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of ethacrynic acid on the guinea-pig and rat isolated vas deferens.
    Khoyi MA; Pousti A; Zarrindast MR
    Br J Pharmacol; 1974 Dec; 52(4):579-84. PubMed ID: 4455332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Voltage and time dependency of calcium mediated phasic and tonic responses in rat vas deferens smooth muscle--the effect of some calcium agonist and antagonist agents.
    Langton PD; Huddart H
    Gen Pharmacol; 1988; 19(6):775-87. PubMed ID: 2465934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An inhibitory role for noradrenaline in the mouse vas deferens.
    Jenkins DA; Marshall I; Nasmyth PA
    Br J Pharmacol; 1977 Dec; 61(4):649-55. PubMed ID: 202361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adrenergic and 'non-adrenergic' contributions to the two-component tetanus in the rat vas deferens.
    Amobi NI; Smith IC
    Eur J Pharmacol; 1987 Mar; 135(2):173-82. PubMed ID: 2884119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A1 adenosine receptor modulation of electrically-evoked contractions in the bisected vas deferens and cauda epididymis of the guinea-pig.
    Haynes JM; Alexander SP; Hill SJ
    Br J Pharmacol; 1998 Jul; 124(5):964-70. PubMed ID: 9692782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adrenergic modulation of 'non-adrenergic' twitches in the rat vas deferens.
    Amobi NI; Smith IC
    J Auton Pharmacol; 1988 Jun; 8(2):141-52. PubMed ID: 2902096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of castration on neurotransmission in the rat vas deferens.
    MacDonald A; McGrath JC
    Br J Pharmacol; 1980 May; 69(1):49-58. PubMed ID: 6103728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of alpha-adrenoceptor agonists and antagonists on responses of transmurally stimulated prostatic and epididymal portions of the isolated vas deferens of the rat.
    Brown CM; McGrath JC; Summers RJ
    Br J Pharmacol; 1979 Aug; 66(4):553-64. PubMed ID: 37964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unexplained inhibitory action of D-lysergic acid diethylamide (LSD) on postganglionic motor transmission in the guinea-pig vas deferens.
    Ambache N; Dunk LP; Miall P; Zar MA
    Br J Pharmacol; 1971 Aug; 42(4):659P-660P. PubMed ID: 4329987
    [No Abstract]   [Full Text] [Related]  

  • 34. Failure of non-adrenergic transmission in the rat vas deferens.
    Ebong OO; Zar MA
    Neuropharmacology; 1989 Apr; 28(4):335-41. PubMed ID: 2546086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholinergic innervation of the guinea-pig isolated vas deferens.
    Solanki P; Cuprian-Beltechi AM; Cunnane TC
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Dec; 376(4):265-74. PubMed ID: 17992517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for ATP and noradrenaline as cotransmitters in sympathetic nerves.
    Burnstock G; Sneddon P
    Clin Sci (Lond); 1985; 68 Suppl 10():89s-92s. PubMed ID: 2857624
    [No Abstract]   [Full Text] [Related]  

  • 37. Prazosin selectively inhibits the responses to field stimulation in the rat vas deferens.
    Doggrell SA
    Eur J Pharmacol; 1981 May; 71(4):447-53. PubMed ID: 6265241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoinhibition, sympathetic cotransmission and biphasic contractile responses to trains of nerve stimulation in the rodent vas deferens.
    Ventura S
    Clin Exp Pharmacol Physiol; 1998 Dec; 25(12):965-73. PubMed ID: 9887992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prazosin has low potency at α1A-adrenoceptors and high potency at α1D -adrenoceptors in rat vas deferens.
    Docherty JR
    Auton Autacoid Pharmacol; 2013 Oct; 33(3-4):49-57. PubMed ID: 24074250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical localization of substance P, vasoactive intestinal polypeptide and gastrin-releasing peptide in vas deferens and seminal vesicle, and the effect of these and eight other neuropeptides on resting tension and neurally evoked contractile activity.
    Stjernquist M; Håkanson R; Leander S; Owman C; Sundler F; Uddman R
    Regul Pept; 1983 Sep; 7(1):67-86. PubMed ID: 6196810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.